Results 121 to 130 of about 31,520 (251)
Annals of Gastroenterological Surgery, Volume 10, Issue 4, Page 1298-1308, July 2026.Emergency cholecystectomy was evaluated in patients with acute cholecystitis classified as non‐recommended for surgery by the Tokyo Guidelines 2018. Major postoperative complications, rather than mortality, better reflected operative risk. Physiological instability, particularly ASA‐PS ≥ 3 and shock status, identified high‐risk patients, suggesting ...
Satoshi Mii +9 more
wiley +1 more source
Acute cholecystitis - Update 2006 [PDF]
, 2006 This update is based on a systemic literature search in Medline.
TOMASI I +2 more
core
Akut acalculosus cholecystitis: a mindennapostól a nagyon ritkáig | Acute acalculous cholecystitis: from common to rare causes [PDF]
Az epekövesség mellett kialakult akut cholecystitis diagnosztikája és terápiája jól meghatározott. A cholecystectomia a leggyakoribb műtétek közé tartozik.
Rácz, István +3 more
core +1 more source
American Journal of Hematology, Volume 101, Issue 7, Page 1597-1604, July 2026.ABSTRACT Sutimlimab is a monoclonal antibody against complement fraction C1s approved for the treatment of hemolytic anemia due to cold agglutinin disease (CAD). Here, we analyzed and report the largest international CAD cohort of sutimlimab‐treated patients ever reported to highlight its safety and effectiveness in the real‐world setting. We accrued a
Bruno Fattizzo +38 more
wiley +1 more source
Safety considerations of gene‐based therapies for Alzheimer's disease
Alzheimer's &Dementia, Volume 22, Issue 7, July 2026.Abstract Gene‐based therapies show increasing promise for the treatment of neurologic disease. In 2016, nusinersen, an RNA‐based therapy, was approved for children with spinal muscular atrophy (SMA). Over 200 clinical trials have utilized gene therapy approaches for a host of neurodegenerative and neuromuscular disorders, including Alzheimer's disease (
Elizabeth A. Bevins +7 more
wiley +1 more source
Clinical Case Reports, Volume 14, Issue 7, July 2026.ABSTRACT Drug‐induced liver injury (DILI) is a leading cause of acute liver failure in the United States and remains difficult to predict and diagnose. Trimethoprim‐sulfamethoxazole (TMP‐SMX) is widely prescribed and generally well tolerated, yet rare cases of severe idiosyncratic hepatotoxicity have been reported.
Kaylie Duit +3 more
wiley +1 more source
Acute acalculous cholecystitis in children [PDF]
, 2013 RESUMO Introdução: A colecistite aguda alitiásica é uma doença rara em Pediatria. Surge geralmente associada a patologias graves, sendo rara na criança saudável.
Santos, T. +3 more
core
IJU Case Reports, Volume 9, Issue 4, July 2026.ABSTRACT Introduction Lenvatinib plus pembrolizumab is a standard first‐line therapy for advanced renal cell carcinoma (RCC), and acute acalculous cholecystitis is a rare adverse event. Case Presentation A 60‐year‐old woman with metastatic TFE3‐positive non–clear cell RCC, classified as poor risk by the International Metastatic RCC Database Consortium (
Erika Soga +9 more
wiley +1 more source
Updates on Antibiotic Regimens in Acute Cholecystitis [PDF]
Acute cholecystitis is one of the most common surgical diseases, which may progress from mild to severe cases. When combined with bacteremia, the mortality rate of acute cholecystitis reaches up to 10–20%.
Valeria Fico +6 more
core +1 more source
Prevalence of Pre‐Clinical Obesity Among US Adults Receiving Medical and Surgical Obesity Treatment
Obesity, Volume 34, Issue 7, Page 1493-1501, July 2026.ABSTRACT Objective We sought to determine how the proportion of adults historically receiving obesity interventions would be classified under the recently proposed “pre‐clinical” and “clinical” obesity classifications and the impact of this change on safety and outcomes.
Jason M. Samuels +4 more
wiley +1 more source